Detalhe da pesquisa
1.
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
Proc Natl Acad Sci U S A
; 120(1): e2209944120, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574650
2.
The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective.
Brain
; 145(2): 426-440, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791056
3.
Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns.
Ann Neurol
; 90(3): 440-454, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231919
4.
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy.
Brain
; 144(9): 2683-2695, 2021 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33757118
5.
Leukoencephalopathy with calcifications and cysts: Genetic and phenotypic spectrum.
Am J Med Genet A
; 185(1): 15-25, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029936
6.
Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.
Acta Neuropathol
; 139(3): 547-564, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31950335
7.
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.
Acta Neuropathol
; 138(3): 443-456, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31030237
8.
Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.
Mult Scler
; 25(12): 1618-1632, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657420
9.
Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.
J Neuroinflammation
; 14(1): 144, 2017 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28738904
10.
Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions.
Acta Neuropathol
; 134(1): 45-64, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28332093
11.
Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.
Acta Neuropathol
; 134(1): 15-34, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28386765
12.
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.
Mult Scler
; 23(1): 72-81, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037182
13.
Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.
Hum Genet
; 135(7): 813-26, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27138983
14.
Extensive acute axonal damage in pediatric multiple sclerosis lesions.
Ann Neurol
; 77(4): 655-67, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25612167
15.
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Ann Neurol
; 78(5): 710-21, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26239536
16.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Mult Scler
; 22(12): 1541-1549, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869529
17.
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.
Neuropathol Appl Neurobiol
; 41(6): 814-31, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641089
18.
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Ann Neurol
; 75(5): 728-38, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771535
19.
Cell type-specific Nrf2 expression in multiple sclerosis lesions.
Acta Neuropathol
; 130(2): 263-77, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26087903
20.
Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study.
Eur Radiol
; 25(1): 122-31, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25129119